Clinical Trial Update: T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated cell-free fetal DNA screening for Trisomy 21, 18, and 13 in low-risk pregnancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome
• Edwards Syndrome
• Patau Syndrome

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Trisomy 21, 18 and 13 Screening | NA | Status: COMPLETED